MEDP Trading Analysis - 10/21/2026 01:59 PM — TRU-SENTIMENT

News Headlines & Context

Medpace Holdings (MEDP) is a clinical research organization providing outsourced services to biopharma and biotech sponsors. Recent general-knowledge context includes:

• MEDP has benefited from sustained biotech funding recovery and sponsor demand for late-phase trial execution through 2026.
• No confirmed near-term earnings date was supplied in the dataset, but fiscal year end is listed as 2025-12-01, suggesting annual reporting cadence distinct from typical calendar Q4.
• Low beta (0.72) indicates relative insulation from broad-market swings versus high-beta peers.
• Clinical outsourcing sector has seen consolidation chatter; MEDP often viewed as potential acquirer or target given $18.18B market cap.
• Headlines context: stable fundamentals and defensive positioning may support the bullish options flow observed in the embedded sentiment data, though no specific catalyst was confirmed in the provided files.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

• Trailing P/E: 35.60; Trailing EPS: $17.39 — valuation is premium versus broad market but typical for specialized CRO with low debt profile implied by missing leverage metrics.
• Market Cap: $18,177,969,120.00; Shares Outstanding: 27,912,000.00.
• Dividend Yield: 0.00% (no income component).
• Beta: 0.72 (lower systemic risk than market).
• 52-Week Range: $373.00 – $677.90; current price near middle-upper band.
• Institutional Ownership: 57.81% — moderate sponsor base.
• Historical Volatility: 27.00%; Average Volume: 265,000.00 shares.
• Missing from data: revenue growth, margins, ROE, D/E, FCF, PEG, forward PE, analyst target — cannot quantify growth quality or consensus.
• Fundamentals show a profitable, low-yield, low-beta large-cap; technicals (price above SMAs) align with stable base rather than distress.

Current Market Position

From daily history, MEDP closed 2026-10-20 at $623.27 (open $626.64, high $637.15, low $613.13, volume 283,231). Minute bars show 2026-10-21 13:30 session at $648.79 (high $649.58, low $644.70, volume 4,996) — intraday uplift from prior close.

Intraday momentum: first 5 bars 2026-10-20 ranged $620.00–$637.15; last 5 bars 2026-10-21 trended $644.70 → $649.58 with rising volume (11,758 to 18,844) indicating late-session buying.

Technical Analysis

SMAs aligned bullish: 5 > 20 > 50 ($621.24 > $614.82 > $607.44). RSI 50.67 neutral-positive. MACD histogram +0.84 bullish crossover. Price inside Bollinger ($597.73–$631.92) but near upper. 30-day range: price at $623.27 sits ~41% up from low, below high $642.64.

True Sentiment Analysis (Delta 40-60 Options)

Options flow for 2026-10-21 13:59:

Call Volume: $156,700.00 (81.70%) Put Volume: $35,030.00 (18.30%) Total: $191,730.00

Sentimento: Bullish. 31 call contracts vs 7 put; 8 call trades vs 2 put. Pure directional conviction skews strongly call-side. Near-term expectation: upward bias confirmed by flow, aligns with SMA alignment and MACD. No divergence vs technicals.

Key Price Levels (observational only)